J
James Fletcher Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
faculty
9 h-index
73 pubs
512 cited
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
James Fletcher's research investigates health outcomes and medical treatments across various populations. His work includes systematic and scoping reviews on frailty in older adults with lung cancer, exploring its impact and measurement. Fletcher has also examined the causes of Botulinum Toxin treatment failure and investigated serum tissue plasminogen activator levels following cycling with blood flow restriction. His publications also address specific clinical cases, such as acquired hemophilia A secondary to immune checkpoint inhibitors and the administration of these inhibitors via teleoncology in rural settings. He has also published on spinal-induced hypotension during caesarean sections.
Fletcher's scholarship metrics include an h-index of 9, with 73 total publications and 269 citations. He has collaborated with Melissa Allen, Jacquie Rainey, Ruth Ann Mathis, and James P. Fletcher, all from the University of Central Arkansas, with multiple shared publications.
Metrics
- h-index: 9
- Publications: 73
- Citations: 512
Selected Publications
-
Effects of open versus closed kinetic chain shoulder resistance exercise training on torque and power: a randomised controlled trial (2025)
-
Effect of Blood Flow Restriction on Serum Brain-Derived Neurotrophic Factor (2025)
-
Serum tissue plasminogen activator after cycling with blood flow restriction (2025)
-
Comparison of 2 Methods for Measuring Chronotropic Response to Exercise: Heart Rate–Work Rate Slope Versus Percent Change in Heart Rate–Work Rate Slope—A Cross-Sectional Study (2024)
-
Nonexercise Measurements as Predictors of Chronotropic Response to Exercise (2022)
Collaboration Network
Top Collaborators
Rahul Ladwa
Princess Alexandra Hospital (AU)
5 shared publications
- The impact of frailty on health outcomes in older adults with lung cancer: A systematic review
- How frail is frail in oncology studies? A scoping review
- How frail is frail in oncology studies? A scoping review
- Lorlatinib After Alectinib-Induced Pneumonitis: A Case Report
- Tolerability of immune checkpoint inhibitors for cancer treatment in frail, older patients
Ruth E. Hubbard
Princess Alexandra Hospital (AU)
5 shared publications
- The impact of frailty on health outcomes in older adults with lung cancer: A systematic review
- How frail is frail in oncology studies? A scoping review
- How frail is frail in oncology studies? A scoping review
- Describing the outcomes of frail patients undergoing treatment with systemic therapies for acute myeloid leukaemia: A systematic review
- Tolerability of immune checkpoint inhibitors for cancer treatment in frail, older patients
Natasha Reid
The University of Queensland (AU)
4 shared publications
- The impact of frailty on health outcomes in older adults with lung cancer: A systematic review
- How frail is frail in oncology studies? A scoping review
- How frail is frail in oncology studies? A scoping review
- Describing the outcomes of frail patients undergoing treatment with systemic therapies for acute myeloid leukaemia: A systematic review
Emily H Gordon
Princess Alexandra Hospital (AU)
3 shared publications
- How frail is frail in oncology studies? A scoping review
- How frail is frail in oncology studies? A scoping review
- Describing the outcomes of frail patients undergoing treatment with systemic therapies for acute myeloid leukaemia: A systematic review
Kenneth J. O’Byrne
Queensland University of Technology (AU)
3 shared publications
- A Mesoporous Gold Sensor Unveils Phospho PD-L1 in Extracellular Vesicles as a Proxy for PD-L1 Expression in Lung Cancer Tissue
- Acquired Hemophilia A Secondary to an Immune Checkpoint Inhibitor: A Case Report
- Lorlatinib After Alectinib-Induced Pneumonitis: A Case Report
Melissa Allen
University of Central Arkansas
3 shared publications
In database
- Serum tissue plasminogen activator after cycling with blood flow restriction
- Comparison of 2 Methods for Measuring Chronotropic Response to Exercise: Heart Rate–Work Rate Slope Versus Percent Change in Heart Rate–Work Rate Slope—A Cross-Sectional Study
- Effect of Blood Flow Restriction on Serum Brain-Derived Neurotrophic Factor
Jacquie Rainey
Conway School of Landscape Design
3 shared publications
In database
- Serum tissue plasminogen activator after cycling with blood flow restriction
- Comparison of 2 Methods for Measuring Chronotropic Response to Exercise: Heart Rate–Work Rate Slope Versus Percent Change in Heart Rate–Work Rate Slope—A Cross-Sectional Study
- Effect of Blood Flow Restriction on Serum Brain-Derived Neurotrophic Factor
Benignus Logan
The University of Queensland (AU)
2 shared publications
- How frail is frail in oncology studies? A scoping review
- How frail is frail in oncology studies? A scoping review
Josh Landers
Lyon College (US)
2 shared publications
- Serum tissue plasminogen activator after cycling with blood flow restriction
- Effect of Blood Flow Restriction on Serum Brain-Derived Neurotrophic Factor
Ibrahim Oladele
University of Arkansas at Little Rock
2 shared publications
In database
- Serum tissue plasminogen activator after cycling with blood flow restriction
- Effect of Blood Flow Restriction on Serum Brain-Derived Neurotrophic Factor
Leah Lowe
University of Central Arkansas
2 shared publications
In database
- Serum tissue plasminogen activator after cycling with blood flow restriction
- Effect of Blood Flow Restriction on Serum Brain-Derived Neurotrophic Factor
Nawab Ali
University of Arkansas at Little Rock
2 shared publications
In database
- Serum tissue plasminogen activator after cycling with blood flow restriction
- Effect of Blood Flow Restriction on Serum Brain-Derived Neurotrophic Factor
Kelly Landers
University of Arkansas at Little Rock (US)
2 shared publications
- Serum tissue plasminogen activator after cycling with blood flow restriction
- Effect of Blood Flow Restriction on Serum Brain-Derived Neurotrophic Factor
Leila Shafiee Hanjani
The University of Queensland (AU)
2 shared publications
- Describing the outcomes of frail patients undergoing treatment with systemic therapies for acute myeloid leukaemia: A systematic review
- Tolerability of immune checkpoint inhibitors for cancer treatment in frail, older patients
Saarth Shiralkar
Royal Bolton Hospital (GB)
1 shared publication
- An Unusual Complication of Electronic Cigarette Use: Missed Inhaled Foreign Body Causing Acute Respiratory Failure
Similar Researchers
Based on overlapping research topics
Sajjad A. Bhatti
University of Arkansas for Medical Sciences
Meta-analysis and systematic reviews
Cancer Treatment and Pharmacology
Health disparities and outcomes
Madeline Butera
University of Arkansas for Medical Sciences
Meta-analysis and systematic reviews
Telemedicine and Telehealth Implementation
Health disparities and outcomes
Syed Mujtaba Ali Naqvi
University of Arkansas for Medical Sciences
Meta-analysis and systematic reviews
Cancer Treatment and Pharmacology
Health disparities and outcomes
Naser Alqurini
University of Arkansas for Medical Sciences
Meta-analysis and systematic reviews
Cancer Treatment and Pharmacology
Health disparities and outcomes
Mir M. Ali
University of Arkansas for Medical Sciences
Meta-analysis and systematic reviews
Telemedicine and Telehealth Implementation
Health disparities and outcomes
Lyle Burdine
University of Arkansas for Medical Sciences
Meta-analysis and systematic reviews
Cancer Treatment and Pharmacology
Health disparities and outcomes